Evidence map›Paper›PMID 38589601›Full record

ArticleNature medicine2024

Maternal diabetes and risk of attention-deficit/hyperactivity disorder in offspring in a multinational cohort of 3.6 million mother-child pairs.

Adrienne Y L Chan, Le Gao, Miyuki Hsing-Chun Hsieh, Lars J Kjerpeseth, Raquel Avelar, Tobias Banaschewski, Amy Hai Yan Chan, David Coghill, Jacqueline M Cohen, Mika Gissler and 18 more

Abstract read
In one paragraph

Article in Nature medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Adrienne Y L Chan *Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, Hong Kong.ORCID 0000-0002-3011-8320
Le Gao *Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, Hong Kong.ORCID 0000-0002-9349-6599
Miyuki Hsing-Chun Hsieh *School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
Lars J Kjerpeseth *Department of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway.ORCID 0000-0002-2033-736X
Raquel AvelarInstitute of Biological Psychiatry, Mental Health Centre Sct Hans, Mental Health Services, Copenhagen, Denmark.
Tobias BanaschewskiDepartment of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Heidelberg, Germany.ORCID 0000-0003-4595-1144
Amy Hai Yan ChanSchool of Pharmacy, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand.
David CoghillDepartments of Paediatrics and Psychiatry, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Victoria, Australia.
Jacqueline M CohenDepartment of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway.
Mika GisslerCentre for Pharmacoepidemiology, Department of Medicine, Karolinska Institutet, Solna, Sweden.ORCID 0000-0001-8254-7525
Jeff HarrisonSchool of Pharmacy, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand.ORCID 0000-0001-8478-7469
Patrick IpDepartment of Paediatrics and Adolescent Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, Hong Kong.
Øystein KarlstadDepartment of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway.
Wallis C Y LauDepartment of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, Hong Kong.ORCID 0000-0003-2320-0470
Maarit K LeinonenKnowledge Brokers, Finnish Institute for Health and Welfare, Helsinki, Finland.ORCID 0000-0002-7631-4749
Wing Cheong LeungDepartment of Obstetrics and Gynaecology, Kwong Wah Hospital, Yau Ma Tei, Hong Kong.
Tzu-Chi LiaoSchool of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
Johan ReutforsCentre for Pharmacoepidemiology, Department of Medicine, Karolinska Institutet, Solna, Sweden.ORCID 0000-0003-1372-4262
Shih-Chieh ShaoSchool of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan.ORCID 0000-0003-4867-6686
Emily SimonoffDepartment of Child and Adolescent Psychiatry, King's College London, Institute of Psychiatry, Psychology and Neuroscience, London, UK.ORCID 0000-0002-5450-0823
Kathryn Choon Beng TanDepartment of Medicine, School of Clinical Medicine, University of Hong Kong, Hong Kong, Hong Kong.ORCID 0000-0001-9037-0416
Katja TaxisGroningen Research Institute of Pharmacy, Unit of PharmacoTherapy, Epidemiology and Economics, University of Groningen, Groningen, The Netherlands.ORCID 0000-0001-8539-2004
Andrew TomlinSchool of Pharmacy, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand.
Carolyn E CestaCentre for Pharmacoepidemiology, Department of Medicine, Karolinska Institutet, Solna, Sweden. carolyn.cesta@ki.se.ORCID 0000-0001-5759-9366
Edward Chia-Cheng LaiSchool of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan. edward_lai@mail.ncku.edu.tw.ORCID 0000-0002-5852-7652
Helga ZoegaCentre of Public Health Sciences, Faculty of Medicine, University of Iceland, Reykjavik, Iceland. h.zoega@unsw.edu.au.ORCID 0000-0003-0761-9028
Kenneth K C ManDepartment of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, Hong Kong. kenneth.man@ucl.ac.uk.ORCID 0000-0001-8645-1942
Ian C K WongDepartment of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, Hong Kong. wongick@hku.hk.ORCID 0000-0001-8242-0014

Funding

EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 Marie Skłodowska-Curie Actions (H2020 Excellent Science - Marie Skłodowska-Curie Actions) 844728EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020) 965381NordForsk 83539Norges Forskningsråd (Research Council of Norway) 273366, 262700Research Grants Council, University Grants Committee (RGC, UGC) 17112020
6 · The paper itself

Abstract

Previous studies report an association between maternal diabetes mellitus (MDM) and attention-deficit/hyperactivity disorder (ADHD), often overlooking unmeasured confounders such as shared genetics and environmental factors. We therefore conducted a multinational cohort study with linked mother-child pairs data in Hong Kong, New Zealand, Taiwan, Finland, Iceland, Norway and Sweden to evaluate associations between different MDM (any MDM, gestational diabetes mellitus (GDM) and pregestational diabetes mellitus (PGDM)) and ADHD using Cox proportional hazards regression. We included over 3.6 million mother-child pairs between 2001 and 2014 with follow-up until 2020. Children who were born to mothers with any type of diabetes during pregnancy had a higher risk of ADHD than unexposed children (pooled hazard ratio (HR) = 1.16, 95% confidence interval (CI) = 1.08-1.24). Higher risks of ADHD were also observed for both GDM (pooled HR = 1.10, 95% CI = 1.04-1.17) and PGDM (pooled HR = 1.39, 95% CI = 1.25-1.55). However, siblings with discordant exposure to GDM in pregnancy had similar risks of ADHD (pooled HR = 1.05, 95% CI = 0.94-1.17), suggesting potential confounding by unmeasured, shared familial factors. Our findings indicate that there is a small-to-moderate association between MDM and ADHD, whereas the association between GDM and ADHD is unlikely to be causal. This finding contrast with previous studies, which reported substantially higher risk estimates, and underscores the need to reevaluate the precise roles of hyperglycemia and genetic factors in the relationship between MDM and ADHD.

Indexed as

Attention Deficit Disorder with HyperactivityDiabetes, GestationalPrenatal Exposure Delayed EffectsAdultChildCohort StudiesFemaleHong KongHumansMaleMothersNew ZealandPregnancyProportional Hazards ModelsRisk FactorsTaiwan

Identifiers

PMID38589601
PMCPMC11108779

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.